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ABSTRACT
OBJECTIVE
To evaluate the relation between intake of ultra-





21 low, middle, and high income countries across 
seven geographical regions (Europe and North 
America, South America, Africa, Middle East, south 
Asia, South East Asia, and China).
PARTICIPANTS
116 087 adults aged 35-70 years with at least 
one cycle of follow-up and complete baseline 
food frequency questionnaire (FFQ) data (country 
specific validated FFQs were used to document 
baseline dietary intake). Participants were followed 
prospectively at least every three years.
MAIN OUTCOME MEASURES
The main outcome was development of IBD, including 
Crohn’s disease or ulcerative colitis. Associations 
between ultra-processed food intake and risk of 
IBD were assessed using Cox proportional hazard 
multivariable models. Results are presented as hazard 
ratios with 95% confidence intervals.
RESULTS
Participants were enrolled in the study between 2003 
and 2016. During the median follow-up of 9.7 years 
(interquartile range 8.9-11.2 years), 467 participants 
developed incident IBD (90 with Crohn’s disease 
and 377 with ulcerative colitis). After adjustment 
for potential confounding factors, higher intake of 
ultra-processed food was associated with a higher risk 
of incident IBD (hazard ratio 1.82, 95% confidence 
interval 1.22 to 2.72 for ≥5 servings/day and 1.67, 
1.18 to 2.37 for 1-4 servings/day compared with <1 
serving/day, P=0.006 for trend). Different subgroups 
of ultra-processed food, including soft drinks, refined 
sweetened foods, salty snacks, and processed meat, 
each were associated with higher hazard ratios for 
IBD. Results were consistent for Crohn’s disease and 
ulcerative colitis with low heterogeneity. Intakes 
of white meat, red meat, dairy, starch, and fruit, 
vegetables, and legumes were not associated with 
incident IBD.
CONCLUSIONS
Higher intake of ultra-processed food was positively 
associated with risk of IBD. Further studies are needed 





Inflammatory bowel disease (IBD), comprised of 
Crohn’s disease and ulcerative colitis, is a chronic 
inflammatory disorder of the gastrointestinal tract. 
The pathophysiology of IBD is thought to be related 
to activation of the intestinal mucosal immune system 
in response to dysbiosis of the gastrointestinal tract 
in genetically susceptible people.1 Diet alters the 
microbiome2 and modifies the intestinal immune 
response and so could play a role in the pathogenesis 
of IBD.3 The incidence of IBD has increased in several 
countries where both diseases were previously 
uncommon.4 This increase has paralleled the adoption 
of a western diet in these countries. Dietary changes 
in such countries, including increased intake of refined 
sugars and dietary fats such as n-6 polyunsaturated 
fatty acids and decreased intake of fibre, have been 
suggested as potential risk factors for the development 
of IBD.5-7
Specific data linking dietary factors with IBD 
in human populations have been limited and 
conflicting.8-10 Most previous studies of diet and IBD 
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Inflammatory bowel disease (IBD) is more common in industrialised nations
It is hypothesised that environmental factors such as diet might influence the 
risk of IBD
Many dietary risk factors have been investigated for an association with IBD, but 
data for an association between ultra-processed food (which contain additives 
and preservatives) intake and IBD are limited
WHAT THIS STUDY ADDS
A higher intake of ultra-processed food was associated with higher risk of IBD
Individual food categories (meats, dairy, starches, fruit, and vegetables) were 
not associated with risk of IBD, suggesting that risk might be related to the food 
itself rather than the way it is processed or ultra-processed 
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have used retrospective or case-control designs.9 10 The 
few prospective studies that have examined dietary 
risk factors have been limited by small numbers 
of participants, lack of adjustment for potential 
confounders, or use of homogenous populations 
confined to individual countries or specific regions of 
countries.6 7 11-15
A recent systematic review synthesised all studies 
that evaluated dietary intake and risk of IBD.10 It was 
evident from the findings that many associations have 
been examined repeatedly, including the association 
of different dietary fats, carbohydrates, proteins, fruit, 
vegetables, fibre, and dairy with IBD.10 Meats have been 
assessed as a whole, with some, but not all, studies 
suggesting an increased odds for the development of 
IBD with higher meat intake.10 16 The systematic review 
also found high intake of total fats, polyunsaturated 
fatty acids, and omega-6 fatty acids to be associated 
with increased risk of IBD. High fibre and fruit intake 
might decrease the risk of Crohn’s disease, and high 
vegetable intake was associated with a decreased risk 
of ulcerative colitis.17 18
Recent attention has focused on the non-nutritional 
components of diet and potential associated risks. 
Processed foods often include many non-natural 
ingredients and additives such as artificial flavours, 
sugars, stabilisers, emulsifiers, and preservatives. 
Detergents and emulsifiers that are added to foods 
might have a detrimental effect on the gut barrier. 
Carboxymethylcellulose has been shown to increase 
bacterial adherence to intestinal epithelium and might 
lead to bacterial overgrowth and infiltration of bacteria 
into the spaces between intestinal villi.19 Polysorbate 
80, an emulsifier commonly used in processed foods, 
increases translocation of bacteria such as Escherichia 
coli across M cells and Peyer’s patches in people with 
Crohn’s disease.20 Associations have been reported 
between diets high in processed foods and development 
of diseases such as cancer and cardiovascular 
disease.21 22 One recent study investigated whether 
ultra-processed foods were associated with risk of IBD 
and did not find any association, but this study was 
limited by few patients with IBD (75 among 105 832 
participants).15
Using information from the Prospective Urban 
Rural Epidemiology (PURE) cohort, we describe the 
association between ultra-processed food intake and 
risk of developing IBD.24-26
Methods
The design and methods of the PURE study have been 
described and published previously.23-25 The first 
and second phases of the study took place between 
1 January 2003 and 31 December 2016 and included 
136 384 adults aged 35-70 years who had dietary 
information assessed. Participants were enrolled 
from 21 countries: Argentina, Bangladesh, Brazil, 
Canada, Chile, China, Colombia, India, Iran, Malaysia, 
Palestine, Pakistan, Philippines, Poland, South Africa, 
Saudi Arabia, Sweden, Tanzania, Turkey, United 
Arab Emirates, and Zimbabwe. The sampling and 
recruitment strategies from PURE have been published 
previously (see supplementary appendix 1).26 Data 
were collected at the community, household, and 
individual level using standardised questionnaires. 
Standard case report forms were used to record new 
diagnoses of Crohn’s disease and ulcerative colitis 
during the follow-up period. For the current analysis, 
the data include all outcome events up to 5 July 
2019. The Population Health Research Institute and 
McMaster University and Hamilton Health Sciences in 
Hamilton, Ontario, Canada coordinated the study.
Procedures
For each participant in PURE, usual food intake was 
assessed at baseline using country specific validated 
food frequency questionnaires (FFQ). Validated 
FFQs were developed for countries where such 
questionnaires had not been available previously 
(supplementary table 1). Participants received a list of 
food items and were asked to input their frequency for 
intake of each item in the past year. To compute daily 
food and nutrient intakes, participant’s answers were 
converted to daily intake and multiplied by United 
States Department of Agriculture (USDA) serving size. 
Ultra-processed food included all types of packaged 
and formulated foods and beverages that contain 
food additives, artificial flavourings, colours, or other 
chemical ingredients. Included in this group were 
processed meat, cold breakfast cereal, various types of 
sauce, soft drinks, refined sweetened foods (eg, candy, 
chocolate, jam, jelly, brownies, pudding), chips, ice 
cream, commercially prepared pastries, biscuits, and 
fruit drinks. To make the unit of consumption consistent 
between countries, we used daily serving intake.
Outcomes
The primary outcome was the development of IBD 
after completion of the baseline questionnaire. Other 
outcomes of interest were development of Crohn’s 
disease and ulcerative colitis individually by dietary risk 
factors that had statistically significant associations 
with the development of IBD overall. Although data 
collection for PURE started in 2003, an amendment 
was implemented in 2014 to record diagnoses of 
Crohn’s disease and ulcerative colitis. Participants 
were asked at every follow-up questionnaire whether 
they had a diagnosis of Crohn’s disease or ulcerative 
colitis. They were asked when the condition was 
diagnosed and those with prevalent diagnoses of 
IBD (diagnosis before baseline questionnaire) were 
excluded. Participants were also excluded if their 
baseline FFQ was completed less than one year from 
the time of the reported IBD diagnosis. Participants 
self-reported the diagnosis. A validation exercise was 
conducted to validate 20% of the diagnoses using a 
sample of the population where medical records could 
be provided for review by the authors.
Statistical analysis
Continuous variables are expressed as means with 
standard deviation, and categorical variables are 
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expressed as percentages. Education was categorised 
as college, university, or trade (age >11 years), 
secondary or high school (age 7-11 years), or none or 
primary school (age <6 years). Alcohol was categorised 
as <1 serving/month (eg, per serving: beer 14 g, wine 
16 g, vodka, rum, spirits 10 g, liqueur 27 g), 1 serving/
month to 1/week, or >1 serving/week. Geographical 
region was treated as binary variable of North America 
and Europe or rest of the world because the prevalence 
of IBD is typically highest in North America and 
Europe and lower in other parts of the world. Other 
binary variables included smoking status (current 
versus no smoking) and location (rural versus urban). 
Other categorical variables included body mass 
index, classified as obese, overweight, or normal, and 
physical activity, classified as low (<600 metabolic 
equivalent of task (MET) min/week), moderate (600-
3000 MET min/week), or high (>3000 MET min/week). 
Continuous variables included age, daily total energy 
(in kcal), and waist to hip ratio.
For the overall analysis of total ultra-processed food, 
participants were grouped into categories according 
to servings as <1 serving/day, 1-4 servings/day, or ≥5 
servings/day. The lowest intake group was always used 
as the reference group. In a sensitivity analysis, we also 
grouped participants based on grams of intake of ultra-
processed food into <50 g/day, 50-99 g/day, and ≥100 g/
day. We also assessed the association using categories 
of ultra-processed foods individually. Processed meat 
was categorised into <1 serving/week, 1-6 servings/
week, or ≥7 servings/week. Soft drink intake was 
categorised into <0.5 serving/week, 0.5 to <3 servings/
week, or ≥3 servings/week. Refined sweetened foods—
those high in refined sugars (eg, cake, cookies)—and 
intake was categorised as none, 1-99 g/day, or ≥100 g/
day. Salty foods and snacks (eg, crackers, potato chips, 
nachos, popcorn) were categorised into <50 g/day, 50-
99 g/day, and ≥100 g/day. An additional analysis of 
urinary sodium was conducted, as a surrogate of dietary 
sodium, to determine whether dietary sodium could 
potentially be implicated should ultra-processed foods 
be associated with risk of IBD. The Kawasaki formula 
was used to estimate urinary sodium excretion.27 
Based on a previous study assessing urinary sodium, 
categories chosen were <2.5 g/day, 2.5-3.4 g/day, 
and ≥3.5 g/day.27 A sensitivity analysis was planned 
to exclude China because of its significantly higher 
observed sodium intake compared with the rest of the 
world and relatively low event rates for IBD.27
Exploratory analyses were planned with other 
dietary variables to confirm or refute risk factors 
that had been reported in the literature as showing 
associations. Participants were categorised by white 
meat intake into <1 serving/week, 1-2 servings/week, 
or ≥3 servings/week. Red meat (unprocessed) was 
categorised into <3 servings/week, 3-6 servings/week, 
or ≥7 servings/week. Dairy intake was categorised into 
<1 serving/day, 1 to <2 servings/day, or ≥2 servings/
day. Starch intake was categorised into <200 g/day, 
200-399 g/day, and ≥400 g/day. Fruit, vegetables, and 
legumes were analysed together and classified as <2 
servings/day, 2-5 servings/day, and ≥6 servings/day 
and were also analysed separately. Lastly, fried foods 
were categorised into none, 1 serving/week to <1 
serving/day, or ≥1 servings/day.
We calculated hazard ratios using multivariable Cox 
proportional hazard models. Estimates of hazard ratios 
and 95% confidence intervals are presented for each 
dietary risk factor of interest. Results are presented 
as unadjusted hazard ratios, minimally adjusted 
hazard ratios for age, sex, and geographical region, 
and fully adjusted hazard ratios. Covariates included 
in the fully adjusted model were those known from 
previous literature to have an association with the 
development of IBD (eg, smoking) or those found to 
have an association on univariable analyses (P<0.15). 
Covariates for consideration in the fully adjusted 
multivariable model included age, sex, geographical 
region, education, alcohol intake, smoking status, 
physical activity, energy intake, BMI, waist to hip 
ratio, and urban versus rural location. An additional 
model was run including adjustment for diet quality 
as measured by the Alternate Health Eating Index 
(AHEI).28 The Kolmogorov-type Supremum test was 
used to test the proportional hazards assumptions.29 
The χ2 test of linear trend was used to compare 
across categories of food intake. A two sided P<0.05 
was considered to be statistically significant. 
Sensitivity analysis were conducted by using multiple 
imputation for participants with missing FFQ data 
to determine whether this had any impact on the 
results. For separate analyses of Crohn’s disease 
and ulcerative colitis conducted when a dietary risk 
factor had statistically significant association with 
development of IBD, we anticipated lower power to 
achieve statistical significance separately within each 
subgroup. For comparison of subgroup effects, we 
assessed heterogeneity by calculating the χ2 and I2 
statistics. For the χ2 test, we considered a P value of 
<0.10 to be statistically significant. I2 values greater 
than 50% were considered to indicate substantial 
heterogeneity. We used heterogeneity of the subgroup 
analyses to determine whether the association was 
predominantly due to effect from one subgroup. Data 
were analysed using Stata/IC 15.
Patient and public involvement
No patients were involved in setting the research 
question or outcome measures, or in the design and 
implementation of this study.
Results
Between 1 January 2003 and 31 December 2016, a 
total of 153 220 participants completed the FFQ. Of 
these participants, 126 662 had a plausible energy 
intake (500-5000 kcal/day; 1 kcal=4.18 kJ or 0.00418 
MJ) and had at least one cycle of follow-up. Overall, 
10 625 (8.3%) were excluded owing to incomplete FFQ 
data, leaving a total of 116 037 participants included 
in this study.
During a median follow-up of 9.7 years (interquartile 
range 8.9-11.2 years), 467 participants (0.4%) had a 
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diagnosis of incident IBD (supplementary figure 1): 
90 participants with Crohn’s disease and 377 with 
ulcerative colitis. Supplementary appendix 2 provides 
the results of the validation exercise.
Ultra-processed food intake was higher in North 
America, Europe, and South America than in other 
regions (table 1), both in servings and grams of intake 
daily. Similarly, processed meat and soft drink intakes 
were highest in these three regions. Consumption of 
refined sweetened foods was highest in South America, 
followed by the Middle East and South East Asia. Salty 
and snack food intake was highest in North America 
and South East Asia. Sodium intake was highest in 
China.
Table 2 summarises the results of the univariable 
associations. Those dietary variables that were 
nominally significant were included in the multivariable 
Cox proportional hazard regression models. In 
addition to age, sex, and geographical region used 
in the minimally adjusted model, education, alcohol 
intake, smoking status, BMI, total energy intake, and 
location were all found to be significantly associated 
with the development of IBD and were included within 
the multivariable model. None of the variables in the 
model violated the proportional hazards assumption 
(P>0.05) when tested using the Supremum test for total 
ultra-processed food intake, individual categories of 
ultra-processed food intake, urinary sodium, and other 
food categories, and the outcome of IBD development.
Ultra-processed food intake and risk of IBD
Table 3 shows the graded association between intake 
of total ultra-processed foods and risk of IBD. Higher 
intake of ultra-processed food was associated with a 
higher risk of incident IBD (hazard ratio 1.82, 95% 
confidence interval 1.22 to 2.72 for ≥5 servings/day 
and 1.67, 1.18 to 2.37 for 1-4 servings/day compared 
with <1 serving/day, P=0.006 for trend). When further 
adjusted using the AHEI, findings were similar, as 
higher risk of IBD was observed for ≥5 servings/day 
(1.92, 1.28 to 2.90) and 1-4 servings/day (1.75, 1.23 
to 2.50) compared with <1 serving/day (P=0.004 
for trend). The results were directionally consistent 
for Crohn’s disease and ulcerative colitis, with no 
statistical evidence of heterogeneity (χ2 P=0.60; 
I2=0%). In sensitivity analysis (supplementary table 
2), the risk of IBD development in participants with 
ultra-processed food intake (g/day) was also found 
to be significantly increased. Higher intake (g/day) of 
ultra-processed food was associated with higher risk 
of incident IBD (1.73, 1.23 to 2.45 for ≥100 g/day and 
1.33, 0.88 to 2.01 for 50-100 g/day compared with 
<50 g/day, P=0.007 for trend). Sensitivity analysis with 
multiple imputation for missing FFQ data also showed 
a higher risk of IBD with increased ultra-processed 
food intake, suggesting that the missing data did not 
alter the findings (table 3). Subgroup analyses were 
performed to determine whether participant age was 
an effect modifier, but similar patterns of increased 
hazard ratios at higher levels of ultra-processed food 
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50 and 50 or older (supplementary tables 3 and 4). 
Region specific analyses (supplementary figure 2) were 
also performed to determine whether the pattern of 
increased ultra-processed food intake and higher risk 
of IBD persisted within each of the regions examined, 
and effect estimates were generally similar, with 
overlapping confidence intervals and no significant 
heterogeneity (χ2 P=0.69; I2=0%).
Supplementary table 5 shows that higher processed 
meat intake was associated with higher risk of IBD 
(2.07, 1.14 to 3.76 for ≥1 serving/day and 1.92, 1.24-
2.98 for 1 serving/week to <1 serving/day compared 
with <1 serving/week, P=0.01 for trend; supplementary 
tables 5-8). Increased risk was observed for both Crohn’s 
disease and ulcerative colitis (tests of heterogeneity: χ2 
P=0.93; I2=0%). A graded risk was also found for soft 
drinks intake and risk of IBD (supplementary table 6). 
The highest intake of soft drinks (≥3 servings/week) 
compared with lowest intake (<0.5 serving/week) was 
associated with a higher risk of IBD (1.94, 1.42 to 
2.66, P<0.001 for trend), with directionally consistent 
results observed for Crohn’s disease and ulcerative 
colitis and no statistical evidence of heterogeneity (χ2 
P=0.72; I2=0%).
Consumption of refined sweetened foods was 
associated with higher risk of IBD (supplementary table 
7). The highest risk of IBD was observed in participants 
with ≥100 g/day intake (2.58, 1.44 to 4.62, P=0.003 
for trend) compared with zero intake. Results were 
consistent for Crohn’s disease and ulcerative colitis 
(tests of heterogeneity: χ2 P=0.17; I2=41%). A similar 
pattern was observed for salty foods and snacks, where 
an increased risk of IBD was observed in participants 
with ≥100 g/day intake compared with <50 g/day 
(2.06, 1.41 to 3.00, P<0.001 for trend; supplementary 
table 8). Associations with similar direction were 
observed for the risk of Crohn’s disease and ulcerative 
colitis, without significant heterogeneity (χ2 P=0.25; 
I2=27.8%).
Urinary sodium and risk of IBD
Urinary sodium was used as a surrogate of dietary 
sodium intake. The risk of IBD in participants with 
higher levels of urinary sodium (≥3.5 g/day) was 
found not to be higher than in those patients with the 
lowest levels of urinary sodium (<2.5 g/day, P=0.61 
for trend; table 4). As a large number of participants 
with IBD was found among the highest urinary sodium 
cohort, a sensitivity analysis was performed to further 
subdivide this cohort (supplementary table 9), but 
again no difference in risk of IBD was observed in 
those with the highest levels of urinary sodium (≥5 g/
day) compared with those with lower levels (P=0.45 
for trend). Although urinary sodium was found to be 
highest among participants from China (table 1) with 
only 19 incident cases of IBD, the results did not differ 
after exclusion of participants from China (P=0.68 for 
trend).
Other food categories and risk of IBD
Several other food categories were evaluated in 
exploratory analyses (table 5 and table 6, also see 




Hazard ratio (95% CI) P value Hazard ratio (95% CI) P value
Age 1.00 (0.99 to 1.01) 0.51 1.01 (0.99 to 1.02) 0.16
Sex (men) 1.03 (0.86 to 1.24) 0.73 0.93 (0.72 to 1.20) 0.59
North America and Europe 4.04 (3.36 to 4.86) <0.001 5.57 (3.97 to 7.81) <0.001
Education: <0.001 0.02
 None 1.00 (ref) 1.00 (ref)
 Secondary or high school 1.26 (1.01 to 1.58) 1.60 (1.13 to 2.26)
 College, university, or trade 2.24 (1.78 to 2.81) 1.57 (1.07 to 2.26)
Alcohol†: <0.001 0.34
 <1 serving/month 1.00 (ref) 1.00 (ref)
 1 serving/ month to <1 serving/week 3.52 (2.46 to 5.04) 1.21 (0.82 to 1.80)
 ≥1 serving/week 2.93 (2.28 to 3.77) 0.92 (0.67 to 1.26)
Current smoking 0.78 (0.61 to 1.00) 0.05 0.73 (0.51 to 1.06) 0.10
Physical activity (MET score): 0.16
 Low (<600) 1.00 (ref)
 Moderate (600 to <3000) 1.28 (0.95 to 1.71)
 High (≥3000) 1.30 (0.98 to 1.74)
Energy (kcal) 1.00 (0.99 to 1.00) 0.13 1.00 (0.99 to 1.00) 0.08
Body mass index: 0.03 0.78
 Normal (<25) 1.00 (ref) 1.00 (ref)
 Overweight (25 to <30) 1.09 (0.88 to 1.34) 0.91 (0.69 to 1.19)
 Obese (≥30) 1.38 (1.09 to 1.75) 0.96 (0.70 to 1.32)
Waist to hip ratio 1.80 (0.61 to 5.28) 0.28
Location: 0.002 0.91
 Urban 1.00 (ref) 1.00 (ref)
 Rural 0.75 (0.62 to 0.90) 0.99 (0.76 to 1.28)
MET=metabolic equivalent of task.
*Ultra-processed food intake in servings per day was used as main predictor.
†For example, per serving: beer 14 g, wine 16 g, vodka, rum, spirits 10 g, liqueur 27 g.
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supplementary tables 10-18 for detailed analyses). 
Intake of white meat, unprocessed red meat, dairy, 
starchy foods, and fruit, vegetables, and legumes was 
not associated with risk of IBD (supplementary tables 
10-17). Intake of fried foods was associated with higher 
risk of IBD (supplementary table 18). Those with a 
fried food intake of ≥1 servings/day showed the highest 
risk of IBD (3.02, 1.51 to 6.03, P=0.006 for trend) 
compared with those with zero intake. No significant 
difference in risk was observed between Crohn’s 
disease and ulcerative colitis (tests of heterogeneity: χ2 
P=0.19; I2=37.6%).
Discussion
In this large, multinational, prospective cohort study 
involving 116 087 participants from 21 low, middle, 
and high income countries, we found that higher 
intake of ultra-processed foods was associated with 
an increased risk of IBD. This was seen for all ultra-
processed foods, as well as individual types, including 
processed meats, soft drinks, refined sweetened foods, 
and salty foods and snacks. No significant heterogeneity 
was observed when the results for Crohn’s disease were 
compared with the results for ulcerative colitis within 
each of these types of ultra-processed foods. These 
results remained consistent in sensitivity analyses 
using alternative classifications for ultra-processed 
food intake and using multiple imputation to account 
for missing FFQ data. The results were still consistent 
after adjustment for a western diet using the AHEI. Our 
findings support the hypothesis that intake of ultra-
processed foods could be an environmental factor that 
increases the risk of IBD.
Comparison with other studies
Processed foods are a diverse food group that include 
meats, dairy, starchy foods, fruit, vegetables, and 
legumes. None of these categories on its own was 
found to be implicated as a risk factor for IBD in our 
study. Recent attention has focused on diet as an 
environmental factor that might be implicated in the 
development of IBD, and studies have suggested that 
western-type diets that are typically high in protein, 
fat, salt, and sugar but low in fruit, vegetables, and 
fibre, are associated with increased risk of IBD.30-32 
A recent meta-analysis suggested western-type diets 
were associated with a relative risk for IBD of 1.92 
(95% confidence interval 1.37 to 2.68).33 Western-type 
diets, however, also contain higher levels of additives 
and preservatives, which could explain the association 
Table 3 | Association between total ultra-processed food intake and risk of inflammatory bowel disease. Values are 
hazard ratios (95% confidence intervals) unless stated otherwise
Ultra-processed food intake
<1 serving/day 1-4 servings/day ≥5 servings/day P trend
Inflammatory bowel disease
No of participants 76 415 25 453 11 742
No (%) of events 199 (0.26) 134 (0.53) 95 (0.81)
Unadjusted model 1 (ref) 2.20 (1.77 to 2.74) 3.18 (2.49 to 4.07) <0.001
Minimally adjusted model* 1 (ref) 1.41 (1.11 to 1.79) 1.42 (1.07 to 1.90) 0.01
Fully adjusted model† 1 (ref) 1.67 (1.18 to 2.37) 1.82 (1.22 to 2.72) 0.006
Fully adjusted plus AHEI score model 1 (ref) 1.75 (1.23 to 2.50) 1.92 (1.28 to 2.90) 0.004
Sensitivity analysis using multiple imputation‡ 1 (ref) 1.54 (1.21 to 1.84) 1.71 (1.22 to 2.37) <0.001
Crohn’s disease
No of participants 76 415 25 453 11 742
No (%) of events 34 (0.04) 23 (0.09) 30 (0.26)
Unadjusted model 1 (ref) 2.19 (1.29 to 3.72) 5.84 (3.57 to 9.54) <0.001
Minimally adjusted model* 1 (ref) 1.15 (0.64 to 2.06) 1.92 (1.05 to 3.49) 0.07
Fully adjusted model† 1 (ref) 2.72 (1.06 to 6.97) 4.50 (1.67 to 12.13) 0.01
Fully adjusted plus AHEI score model 1 (ref) 2.93 (1.13 to 7.60) 4.90 (1.78 to 13.45) 0.008
Sensitivity analysis using multiple imputation‡ 1 (ref) 1.30 (0.71 to 2.37) 2.83 (1.45 to 4.65) 0.40
Ulcerative colitis
No of participants 76 415 25 453 11 742
No (%) of events 165 (0.22) 111 (0.44) 65 (0.55)
Unadjusted model 1 (ref) 2.20 (1.73 to 2.80) 2.63 (1.97 to 3.51) <0.001
Minimally adjusted model* 1 (ref) 1.48 (1.13 to 1.93) 1.27 (0.91 to 1.77) 0.02
Fully adjusted model† 1 (ref) 1.55 (1.06 to 2.28) 1.46 (0.93 to 2.28) 0.08
Fully adjusted plus AHEI score model 1 (ref) 1.61 (1.09 to 2.38) 1.52 (0.96 to 2.41) 0.06
Sensitivity analysis using multiple imputation‡ 1 (ref) 1.59 (1.23 to 1.98) 1.45 (0.96 to 2.12) <0.001
AHEI=Alternate Healthy Eating Index.
Heterogeneity of results from Crohn’s disease and ulcerative colitis: χ2 P=0.595; I2=0%.
*Adjusted for age, sex, and geographical region.
†Adjusted for age, sex, geographical region, education, alcohol intake, smoking status, body mass index, total energy intake, and location.
‡To account for participants with missing data on food frequency questionnaire.
Table 4 | Association between urinary sodium intake and risk of inflammatory bowel 
disease. Values are hazard ratios (95% confidence intervals) unless stated otherwise
Sodium intake (g/day)
<2.5 2.5 to <3.5 ≥3.5 P trend
No of participants 8444 11 555 61 033
No (%) of events 42 (0.50) 73 (0.62) 269 (0.44)
Unadjusted 1 (ref) 1.33 (0.91 to 1.95) 0.89 (0.64 to 1.23) 0.008
Minimally adjusted* 1 (ref) 1.88 (1.28 to 2.76) 1.66 (1.18 to 2.34) 0.004
Fully adjusted† 1 (ref) 1.26 (0.80 to 1.97) 1.17 (0.79 to 1.74) 0.61
*Adjusted for age, sex, and geographical region.
†Adjusted for age, sex, geographical region, education, alcohol intake, smoking status, body mass index, total 
energy intake, and location.
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with higher risk of IBD. We hypothesised that increased 
sodium intake could be implicated, as various animal 
models have shown increased dietary sodium to 
be associated with exacerbation of autoimmune 
conditions, including collagen induced rheumatoid 
arthritis34 and 2,4,6-trinitrobenzenesulfonic acid 
induced colitis for IBD.35 In our study, however, we 
found no relation between urinary sodium, a surrogate 
for dietary sodium intake, and development of IBD. 
This suggests that components other than sodium in 
ultra-processed foods might be responsible for the 
higher risk of IBD observed with higher consumption 
of salty snacks.
Further studies are required to identify potential 
contributory factors in ultra-processed foods. 
Preclinical studies in mice models found that 
emulsifiers, which are widely used in western diets and 
include carboxymethylcellulose and polysorbate 80, 
induce thinning of the mucosal layer and dysbiosis and 
promote development of colitis and colitis associated 
colon cancer.36-38 In preclinical studies other additives 
that have been implicated include maltodextrin39 40 
and titanium dioxide.41 Intake of foods containing 
these types of additives could be a plausible pathway 
for disruption of gut microbiota and propagation of the 
subsequent immune activation that occurs in IBD.
Recent studies have assessed the association 
between processed food intake and IBD. One study 
from Romania and Belgium reported that participants 
with IBD were more likely to report higher intake of 
refined sweetened foods, processed and high fat meats, 
fried food, salt, ice cream, mayonnaise, margarine, 
and chips or other snacks compared with healthy 
controls. A US study using data from the National 
Health Interview Study in 2015 reported higher intake 
of cheese, cookies, French fries, sports drinks, and 
soda among participants with IBD compared with no 
IBD. These studies, however, had design limitations, 
including using a case-control or retrospective design, 
which are vulnerable to recall bias. A nested matched 
case-control study conducted using the large European 
Prospective Investigation into Cancer and Nutrition 
(EPIC) prospective database found that diets of high 
sugar and soft drink intake and low vegetable intake 
were associated with an increased risk of ulcerative 
colitis.5 A prospective study using data from the Nurses 
Health Study II cohort found that participants with a 
“prudent” dietary pattern in high school (higher intake 
of vegetables, fibre, and fish) showed a lower risk of 
subsequent Crohn’s disease.42 A French study using the 
NutriNet-Sante prospective cohort did not find higher 
intake of ultra-processed foods among participants 
who subsequently developed IBD compared with those 
who did not, after adjustment for confounders, but this 
study might have been underpowered because of too 
few participants (n=75) with IBD.15
We also found higher intake of fried food to be 
associated with higher risk of IBD. This association 
might exist because many fried foods are also processed 
(eg, chicken nuggets, French fries). It could be that 
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modification of nutrients within the food.43 44 The type 
and quality of oil used might also be relevant.45
In our study, intake of white meat, unprocessed 
red meat, dairy, starch, and fruit, vegetables, and 
legumes were not found to be associated with risk of 
IBD. Recent meta-analyses that included high quality 
studies found no associations between pre-illness 
intake of carbohydrates, sugar, protein, or fat for either 
Crohn’s disease or ulcerative colitis.46-48 Although 
some studies have suggested increased meat intake 
could increase the risk of IBD,10 16 and higher fruit and 
vegetable intake might be protective,17 18 these findings 
have not been found consistently in all studies that 
have examined this potential association.10 49 50 This 
finding could be partly due to study design limitations, 
particularly in case-control studies where the selection 
of controls might have an impact on associations being 
evaluated.
For positive associations found in our study, similar 
directional effects were observed for Crohn’s disease 
and ulcerative colitis. Overall, a lower number of 
participants with Crohn’s disease were observed in our 
study (n=90) compared with ulcerative colitis (n=377). 
Reasons for the higher incidence of ulcerative colitis 
compared with Crohn’s disease in our study probably 
reflects participants being from developing nations, 
where ulcerative colitis is known to be relatively more 
prevalent.51 Furthermore, the age of participants in the 
PURE study was 35-70 years, and the risk of Crohn’s 
disease is lower at older ages, whereas ulcerative colitis 
has a bimodal peak, with many patients receiving a 
diagnosis in their 50s and 60s.1 52
Strengths and limitations of this study
We investigated dietary risk factors for IBD in a 
large prospective multinational cohort study. The 
study design overcomes the limitations of many 
of the existing studies in this specialty, which are 
retrospective or case-control in design and restricted 
to homogenous populations with limited external 
validity.10 The longitudinal design of our study allowed 
us to focus on people with incident IBD and to use 
medical record review and central adjudication to 
validate a sample of the diagnoses. Information on diet 
was collected at baseline before diagnosis to minimise 
risk of bias from reverse causation or recall bias. 
We excluded participants who received a diagnosis 
within one year of the baseline FFQ assessment to 
account for the possibility of dietary changes related 
to gastrointestinal symptoms that would later lead to a 
diagnosis of IBD. Validated, standardised, and country 
specific questionnaires were used for collection of 
dietary information. Because other baseline covariates 
on univariable analysis were found to be associated 
with risk of IBD, including smoking status and location, 
the validity of our study findings was increased.53 54 We 
also identified other factors on univariable analysis, 
such as alcohol intake and BMI, that were significant 
but possibly correlated with other confounding factors 
and when put into a multivariable model were no longer 
associated with risk of IBD (analyses not shown).
Nonetheless, our study also has some potential 
limitations. Owing to the age of participants in 
the PURE study (35-70 years), incident Crohn’s 
disease was observed in a relatively small number of 
participants, which might have resulted in our study 
being underpowered to determine risk factors for 
Crohn’s disease. Furthermore, the generalisability of 
these findings to patients who develop IBD at an earlier 
age (children or young adulthood) is unclear. We did, 
however, run subgroup analyses to determine whether 
age was an effect modifier and found similar increased 
hazard ratios for risk of IBD in those younger than or 
older than 50 years. Only a sample of participants 
with IBD were selected for validation, which increases 
the risk of misclassification for cases that did not 
undergo verification processes, but misclassification of 
participants with IBD would tend to bias associations 
to the null and this should not affect our findings. We 
did not account for dietary changes over time, but 
dietary intake as measured by the FFQ has been shown 
to be relatively stable over time.55 During follow-up, 
however, some of the diets in included countries might 
have become partly westernised, which could lead 
to inaccuracy in capturing the degree of processed 
foods and their influence in these participants. FFQs 
are not an ideal instrument for measuring absolute 
intake—however, FFQs might still be useful to assess 
relative intake, so our results should be taken in the 
context of higher versus lower levels of ultra-processed 
food intake.56 Multiple comparisons were made and 
a possibility remains of positive results being found 
owing to chance alone. Our findings did, however, 
show a high level of statistical significance, thereby 
providing some reassurance that our observations 
are probably real. Lastly, although we were able to 
adjust for many variables through our multivariable 
models, owing to the observational nature of our 
study the possibility of residual bias from unmeasured 
(eg, antibiotic use in early childhood), imprecisely 
measured, or unknown confounders remains.
Conclusions
In this study, higher ultra-processed food intake 
was associated with higher risk of IBD. As white 
meat, unprocessed red meat, dairy, starch, and fruit, 
vegetables, and legumes were not found to be associated 
with development of IBD, this study suggests that it 
might not be the food itself that confers this risk but 
rather the way the food is processed or ultra-processed. 
A possibility also remains of residual confounding 
owing to unmeasured or unknown confounders. 
Further studies are needed to identify specific potential 
contributory factors among processed foods that might 
be responsible for the observed associations in our 
study.
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